Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/29/2004EP1490495A2 Bone generation by gene therapy
12/29/2004EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
12/29/2004EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004EP1490491A2 Use of the protein maba (fabg1) of i mycobacterium tuberculosis /i for designing and screening antibiotics
12/29/2004EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004EP1490482A1 Host cells having improved cell survival properties and methods to generate such cells
12/29/2004EP1490481A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
12/29/2004EP1490406A1 Costimulatory molecule and its use
12/29/2004EP1490404A1 Lactoferrin
12/29/2004EP1490402A1 Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue
12/29/2004EP1490401A1 Vegf peptides and their use
12/29/2004EP1490400A2 Tenascin-w compositions and uses thereof
12/29/2004EP1490399A2 Human diabetes-mediating proteins
12/29/2004EP1490398A2 Tumour associated antigens
12/29/2004EP1490397A1 Novel bacillus thuringiensis insecticidal proteins
12/29/2004EP1490396A2 Immunogenic hiv peptides for use as reagents and vaccines
12/29/2004EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004EP1490389A2 Hepatitis c virus sub-genomic replicons
12/29/2004EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004EP1490381A1 Human gene critical to fertility
12/29/2004EP1490112A1 Method and agent for producing therapeutically active blood compositions
12/29/2004EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004EP1490109A2 Egfr ligands and methods of use
12/29/2004EP1490108A2 Drg11-responsive (dragon) gene family
12/29/2004EP1490105A2 Multiple and multivalent dna vaccines in ovo
12/29/2004EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination
12/29/2004EP1490089A1 Peptides selectively lethal to malignant and transformed mammalian cells
12/29/2004EP1490087A2 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
12/29/2004EP1490086A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
12/29/2004EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004EP1490084A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
12/29/2004EP1408736A4 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
12/29/2004EP1397036A4 Xrcc1 and uses thereof
12/29/2004EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004EP1295230A4 Method and system for foreign exchange price procurement and automated hedging
12/29/2004EP1294929A4 Method to detect modulators of vegf kinase domain
12/29/2004EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
12/29/2004EP1278883B1 E. coli extract for protein synthesis
12/29/2004EP1255852A4 Immunoassay and diagnostic reagent for malaria
12/29/2004EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004EP1196581B1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained
12/29/2004EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004EP1146909A4 Method of treating cancer by restoration of pp32 function
12/29/2004EP1090033B1 Particles of hcv envelope proteins: use for vaccination
12/29/2004EP1084251B1 Attenuated pestiviruses
12/29/2004EP1066375B1 $i(LACTOBACILLI) HARBORING AGGREGATION AND MUCIN BINDING GENES AS VACCINE DELIVERY VEHICLES
12/29/2004EP1066045B1 Mammalian-derived peptides for the treatment of microbial infection
12/29/2004EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials
12/29/2004EP1027372B1 Methods, kits and compositions pertaining to linear beacons
12/29/2004EP1011720B1 Mucosal cytotoxic t lymphocyte responses
12/29/2004EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
12/29/2004EP0959975B1 Novel affinity ligands and their use
12/29/2004EP0954527B1 Glycine transporter-transfected cells and uses thereof
12/29/2004EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004EP0890361B1 HGF mutant and its use as an anticancer agent
12/29/2004EP0868431B1 Protein with plant protecting properties
12/29/2004EP0858505B1 Cloning of vertebrate pheromone receptors and uses thereof
12/29/2004EP0830130B9 Tnf-alpha converting enzyme
12/29/2004EP0785946B1 Materials for the production of nanometer structures and use thereof
12/29/2004EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine
12/29/2004CN1559007A Assay for paralytic shellfish toxin
12/29/2004CN1558952A Pegylated and diglycosylated erythropoietin
12/29/2004CN1558916A Compositions and methods for generating chimeric heteromultimers
12/29/2004CN1558915A Leukocyte inactivation module
12/29/2004CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation
12/29/2004CN1558912A Method for making acylated polypeptides
12/29/2004CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
12/29/2004CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer
12/29/2004CN1557952A Solanum lycopersicoides dun. S1Ve1 receptor protein encoding sequence and use thereof
12/29/2004CN1557950A Method of preparing lactoferritin and lactoperoxidase
12/29/2004CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same
12/29/2004CN1557480A Preparation and application of insulin-like growth factors
12/29/2004CN1557281A Skin apolexis preventing delaying polypeptide and compositions
12/29/2004CN1182399C Removal of prions from blood, plasma and other liquids
12/29/2004CN1182243C Technique method for preparing nitrile hydratase by using glucose-CO2+ coupling adding ferment
12/29/2004CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application
12/29/2004CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
12/29/2004CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004CN1181885C Administration of polypeptide growth factors after central nervous system ischemia or trauma
12/29/2004CA2570502A1 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use
12/29/2004CA2570464A1 Use of cardiotrophin to modulate stem cell proliferation
12/29/2004CA2570407A1 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004CA2534748A1 Relaxin superfamily peptide analogues
12/29/2004CA2530049A1 Methods and means for delaying seed shattering in plants
12/29/2004CA2530043A1 Modulation of coffee flavour precursor levels in green coffee grains
12/29/2004CA2529997A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004CA2529986A1 Novel surface protein (hbsag) variant of hepatitis b virus
12/29/2004CA2529882A1 Cell line and uses thereof
12/29/2004CA2529838A1 Isoforms of eif-5a: senescence-induced eif5a; wounding-induced eif-5a; growth eif-5a; and dhs
12/29/2004CA2529639A1 Detection of survivin in the biological fluids of cancer patients
12/29/2004CA2529587A1 Plant transcriptional activator and uses thereof
12/29/2004CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof